Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Psychiatric implications of anti-seizure medications in epileptic population.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background and Objective: Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is associated with a high occurrence of psychiatric comorbidities, which can significantly affect the quality of life of individuals affected. The aim of this study was to investigate the association between antiseizure therapies and the likelihood of psychiatric comorbidities in individuals with epilepsy.
      Methodology: Data for this study was gathered from the Neurology referral center in Islamabad, Pakistan. A standardized questionnaire was utilized to gather data from 120 individuals diagnosed with epilepsy. The survey consisted of inquiries regarding the management of seizures, the utilization of anti-seizure medications, and the presence of psychiatric comorbidities. The data was analyzed using the Statistical Package for the Social Sciences (SPSS).
      Results: The findings indicated that individuals who were using multiple antiseizure medications had a notably higher likelihood of having psychiatric comorbidities in comparison to those who were on mono therapy (p = 0.010). suggests that patients with unsuccessful seizure control are more probable to have psychiatric comorbidities as compared to those with good seizure control (p = 0.029).
      Conclusion: To conclude poor seizure control and poly therapy are associated with increased risk of psychiatric comorbidities.
      (© 2024. The Author(s).)
    • References:
      Epilepsia. 2007 Sep;48(9):1639-1651. (PMID: 17565593)
      Epilepsia. 2011 Jan;52 Suppl 1:21-7. (PMID: 21214536)
      Acta Neurol Scand. 2004 Oct;110(4):207-20. (PMID: 15355484)
      Ann Neurol. 2000 Feb;47(2):246-9. (PMID: 10665498)
      Eur J Clin Pharmacol. 2010 Nov;66(11):1151-60. (PMID: 20669014)
      Epilepsy Behav. 2016 Nov;64(Pt B):306-308. (PMID: 27884642)
      Br J Psychiatry. 1987 Jul;151:95-101. (PMID: 3118998)
      Epilepsia. 2005 Apr;46(4):470-2. (PMID: 15816939)
      Epilepsia. 2010 Apr;51(4):676-85. (PMID: 20196795)
      Discoveries (Craiova). 2020 Jun 12;8(2):e110. (PMID: 32577498)
      Epilepsia. 2014 Apr;55(4):475-82. (PMID: 24730690)
      Lancet. 2015 Aug 22;386(9995):743-800. (PMID: 26063472)
      Epilepsy Res. 2018 Jan;139:73-79. (PMID: 29197668)
      J Epilepsy Res. 2022 Jun 30;12(1):21-26. (PMID: 35910325)
      Epilepsia. 2007 Dec;48(12):2336-44. (PMID: 17662062)
      Curr Neuropharmacol. 2019;17(1):99-106. (PMID: 29119932)
      J Clin Neurol. 2014 Jul;10(3):175-88. (PMID: 25045369)
      JAMA. 2016 Dec 27;316(24):2657-2668. (PMID: 28027373)
      Neurology. 2005 Aug 23;65(4):535-40. (PMID: 16116112)
    • Contributed Indexing:
      Keywords: Antiseizure medications; Epilepsy; MRI findings; Psychiatric comorbidities; Valproate
    • الموضوع:
      Date Created: 20240521 Date Completed: 20240522 Latest Revision: 20240524
    • الموضوع:
      20240524
    • الرقم المعرف:
      PMC11106872
    • الرقم المعرف:
      10.1186/s12883-024-03670-8
    • الرقم المعرف:
      38773441